Search

Your search keyword '"Davies AN"' showing total 3,127 results

Search Constraints

Start Over You searched for: Author "Davies AN" Remove constraint Author: "Davies AN" Journal blood Remove constraint Journal: blood
3,127 results on '"Davies AN"'

Search Results

1. The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma

2. Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

3. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels

8. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

12. Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiency

13. Somatic Hypermutation in Enhancer Regions Shapes Non-Coding Myeloma Genome, Generating DNA Breaks and Driving Etiology through Mutation and Structural Variation

15. Inherited genetic susceptibility to acute lymphoblastic leukemia in Down syndrome

16. Testing for t(3;8) in MYC/BCL6-rearranged large B-cell lymphoma identifies a high-risk subgroup with inferior survival

17. A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology

19. Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

20. Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

21. The presence of large focal lesions is a strong independent prognostic factor in multiple myeloma

22. Replacing Procarbazine with Dacarbazine in Escalated Beacopp Dramatically Reduces the Post Treatment Haematopoietic Stem and Progenitor Cell Mutational Burden in Hodgkin Lymphoma Patients with No Apparent Loss of Clinical Efficacy

23. Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study

26. Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCL

27. USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

31. A Randomized, Placebo-Controlled, Phase 1 Study in Healthy Adult Volunteers of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ALPN303, a Potent Dual BAFF/APRIL Antagonist for the Treatment of Autoimmune Cytopenias

33. Genomic Determinants of Resistance in Newly Diagnosed Multiple Myeloma Treated with Targeted-Immunotherapy

34. Tracking the Earliest Genomic Events in Multiple Myeloma Life-History

35. Fc-Mediated Antibody Effector Function, Inflammation Resolution and Oligoclonality on TCR Rearrangements Predict Sustained MRD Negativity in Newly Diagnosed Multiple Myeloma Treated with Immunotherapy Regimens

36. Five-Year Survival Results from the Remodl-B Trial (ISRCTN 51837425) Show Improved Outcomes in Diffuse Large B-Cell Lymphoma Molecular Subgroups from the Addition of Bortezomib to R-CHOP Chemoimmunotherapy

37. Second Primary Malignancy Incidence in Patients Receiving Lenalidomide at Induction and Maintenance; Long-Term Follow up of 4358 Patients Enrolled to the Myeloma XI Trial

38. Individualized Treatment-Adjusted Risk Stratification in Newly Diagnosed Multiple Myeloma

39. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

40. Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

42. IL-4 enhances expression and function of surface IgM in CLL cells

46. Redefining nonmeasurable multiple myeloma using mass spectrometry

49. Genomic profiling for clinical decision making in lymphoid neoplasms

50. Variability in Pattern of Mutational Signatures in Multiple Myeloma As a Function of Racial Origin

Catalog

Books, media, physical & digital resources